Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

May 2027 82

  1. Study completion Efficacy of Montelukast on STEMl Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07320625

  2. Primary completion Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07441382

  3. Study start Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762560

  4. Primary completion EECP for Erectile Dysfunction in Elderly Hypertensive Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07831551

  5. Study completion A Study of the ReCor Medical Paradise System in Clinical Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02649426

  6. Primary completion Endovascular Acute Stroke Intervention - Tandem OCclusion Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04261478

  7. Study completion Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05164107

  8. Primary completion Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05164107

  9. Primary completion Semaglutide to Reduce Atrial Fibrillation Burden Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05209165

  10. Primary completion GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05356104

  11. Primary completion Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05378347

  12. Primary completion Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05846893

  13. Study completion Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05968430

  14. Primary completion A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06897475

  15. Study completion Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07113223

  16. Study completion A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07215559

  17. Study completion Heart Failure Management for Patient With CIED Remotely Monitored Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07247032

  18. Primary completion Heart Failure Management for Patient With CIED Remotely Monitored Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07247032

  19. Primary completion Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07267949

  20. Study completion Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07487103

  21. Study completion A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613307

  22. Primary completion A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613307

  23. Primary completion A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07783802

  24. Primary completion A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647003

  25. Primary completion The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05464095

  26. Study completion Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04561739

  27. Primary completion Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06281977

  28. Study completion Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05030428

  29. Primary completion Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05030428

  30. Primary completion To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05426785

  31. Primary completion Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220759

  32. Primary completion Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07697833

  33. Study completion A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07082114

  34. Primary completion REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07213778

  35. Study completion Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06168994

  36. Study completion A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06731075

  37. Study completion A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07619118

  38. Primary completion A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07619118

  39. Study completion EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05284747

  40. Primary completion EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05284747

  41. Study completion Management of the PDA Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03456336

  42. Study completion LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05786417

  43. Primary completion LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05786417

  44. Primary completion Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06733246

  45. Study completion Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06954155

  46. Study completion A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156500

  47. Study completion A Phase 3 Study of HS-20094 in Patients With T2DM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156539

  48. Primary completion Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405216

  49. Study completion NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04055428

  50. Study completion GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06003153

  51. Primary completion GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06003153

  52. Study completion Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06528262

  53. Primary completion Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06528262

  54. Study completion A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06610526

  55. Primary completion A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06610526

  56. Primary completion Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06797401

  57. Primary completion Virtual Reality's Impact on Upper Limb Function in Post-stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06881680

  58. Study completion Augmenting Cerebral Blood Flow in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06911385

  59. Primary completion Augmenting Cerebral Blood Flow in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06911385

  60. Primary completion Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07034690

  61. Primary completion Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07049120

  62. Primary completion Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07249853

  63. Study completion Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07250763

  64. Primary completion Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07523620

  65. Study completion Ivabradine in the Acute Management of Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07714746

  66. Primary completion Ivabradine in the Acute Management of Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07714746

June 2027 167

  1. Study completion Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03423511

  2. Study completion A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03807531

  3. Primary completion Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04505618

  4. Study completion NeVa ONE Registry Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04562194

  5. Study completion The COCOA-PAD II Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04794530

  6. Primary completion SELUTION4BTK Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05055297

  7. Study completion Home BP Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05552547

  8. Primary completion Home BP Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05552547

  9. Study completion Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05784051

  10. Primary completion Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05784051

  11. Study completion Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05850091

  12. Primary completion Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05850091

  13. Primary completion AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06235112

  14. Primary completion Acupuncture for Prediabetes With Combined Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06359418

  15. Study completion Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06414187

  16. Primary completion Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06414187

  17. Study completion Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06658197

  18. Study completion TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06802081

  19. Study completion Focused Orticumab Research for Treating Inflammation in Coronary Arteries Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06927739

  20. Study completion Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07002476

  21. Study completion Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07173855

  22. Primary completion Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07211035

  23. Study completion Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220525

  24. Primary completion Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220525

  25. Primary completion Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07263035

  26. Primary completion Central Haemodynamics and Pacing for AV Block Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07276490

  27. Study completion Design and Rationale of the COLT Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07432529

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy Registry record

    Expected 2018-08-01; that period ended on 2018-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03262363

  2. Study start Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence Registry record

    Expected 2018-08-01; that period ended on 2018-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03592823

  3. Study completion the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy Registry record

    Expected 2018-08-10; that period ended on 2018-08-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03230851

  4. Primary completion Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01500590

  5. Study completion Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02007837

  6. Primary completion The European Bifurcation Club Left Main Study Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02497014

  7. Study completion The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02516826

  8. Primary completion The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02516826

  9. Study completion The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02646267

  10. Primary completion Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02770664

  11. Study completion Apixaban Dose Reduction in Patients With Elevated Drug Levels Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02809469

  12. Primary completion Apixaban Dose Reduction in Patients With Elevated Drug Levels Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02809469

  13. Study completion Compare the Effects of Telemedicine Approach With Usual Care in Hypertension Management in China Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02919033

  14. Primary completion Compare the Effects of Telemedicine Approach With Usual Care in Hypertension Management in China Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02919033

  15. Study start VitaFlowTM II Transcatheter Aortic Valve System Study Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03575039

  16. Study start DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris Registry record

    Expected 2018-08; that period ended on 2018-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03633890

  17. Primary completion EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01084993

  18. Study completion Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01681381

  19. Study completion Mid-HDF Randomized Controlled Study on Outcome Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01693354

  20. Study completion Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02225756

  21. Primary completion Randomized All-comer Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02328898

  22. Study completion Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS) Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02484027

  23. Study completion High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02534155

  24. Primary completion Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02541877

  25. Study completion Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02655718

  26. Primary completion Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02655718

  27. Study completion Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02916485

  28. Study completion Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study Registry record

    Expected 2018-09-30; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03398096

  29. Primary completion Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) Registry record

    Expected 2018-09-30; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03486561

  30. Study start Optimizing Patient Usability Experience for Chronic Care Registry record

    Expected 2018-09; that period ended on 2018-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03628963

  31. Primary completion Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring Registry record

    Expected 2018-10-01; that period ended on 2018-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03426982

  32. Study completion Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring Registry record

    Expected 2018-10-30; that period ended on 2018-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03426982

  33. Study start Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients Registry record

    Expected 2018-10-30; that period ended on 2018-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03673241

  34. Study completion Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe Registry record

    Expected 2018-10; that period ended on 2018-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01661231

  35. Study completion Frailty and Cognitive Function Assessment of TAVI Patients Registry record

    Expected 2018-10; that period ended on 2018-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02650388

  36. Study completion Catheter Ablation of Longstanding Persistent Atrial Fibrillation Registry record

    Expected 2018-10; that period ended on 2018-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02929836

  37. Primary completion Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes Registry record

    Expected 2018-10; that period ended on 2018-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03159052

  38. Study completion Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) Registry record

    Expected 2018-10-31; that period ended on 2018-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03486561

  39. Study completion Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia Registry record

    Expected 2018-10; that period ended on 2018-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03639480

  40. Primary completion Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia Registry record

    Expected 2018-10; that period ended on 2018-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03639480

  41. Study start tDCS to Treat Hemiplegic Shoulder Pain Registry record

    Expected 2018-11-01; that period ended on 2018-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02929784

  42. Study start Efficacy and Safety of Balloon Guide Catheter in Mechanical Thrombectomy Patients Registry record

    Expected 2018-11-25; that period ended on 2018-11-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03754738

  43. Study completion Sedation Depth in Neurocritical Care Registry record

    Expected 2018-11; that period ended on 2018-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02317497

  44. Primary completion Once-a-day Tacrolimus Conversion Study: The OneTAC Trial Registry record

    Expected 2018-11; that period ended on 2018-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02545972

  45. Study completion The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein Registry record

    Expected 2018-11-30; that period ended on 2018-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02562183

  46. Primary completion The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein Registry record

    Expected 2018-11-30; that period ended on 2018-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02562183

  47. Study completion Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke Registry record

    Expected 2018-11; that period ended on 2018-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02607943

  48. Primary completion TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI Registry record

    Expected 2018-11-30; that period ended on 2018-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03145194

  49. Study completion Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) Registry record

    Expected 2018-11; that period ended on 2018-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03249285

  50. Study start Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets Registry record

    Expected 2018-12-01; that period ended on 2018-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03605433

  51. Study start Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease Registry record

    Expected 2018-12-01; that period ended on 2018-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03700645

  52. Study start Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response Registry record

    Expected 2018-12-01; that period ended on 2018-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03715556

  53. Study start Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke. Registry record

    Expected 2018-12-01; that period ended on 2018-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03733002

  54. Study completion Development and Evaluation of a Novel Portable Robotic Gait Rehabilitation in Chronic Stroke Registry record

    Expected 2018-12-10; that period ended on 2018-12-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03444688

  55. Primary completion Development and Evaluation of a Novel Portable Robotic Gait Rehabilitation in Chronic Stroke Registry record

    Expected 2018-12-10; that period ended on 2018-12-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03444688

  56. Study start A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT Registry record

    Expected 2018-12-20; that period ended on 2018-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03716011

  57. Study completion Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) Registry record

    Expected 2018-12-30; that period ended on 2018-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02831088

  58. Primary completion Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) Registry record

    Expected 2018-12-30; that period ended on 2018-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02831088

  59. Primary completion Local Paclitaxel or Balloon Angioplasty Below the Knee Registry record

    Expected 2018-12-30; that period ended on 2018-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03149913

  60. Primary completion The Effects of Empagliflozin on Arterial Wall Characteristics Registry record

    Expected 2018-12-30; that period ended on 2018-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03639545

  61. Study completion Study of the Orsiro Drug Eluting Stent System Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01356888

  62. Study completion Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD) Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01377285

  63. Primary completion Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD) Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01377285

  64. Study completion The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01674686

  65. Primary completion The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01674686

  66. Study completion ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01717911

  67. Study completion Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01913847

  68. Primary completion Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01913847

  69. Study completion The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01942109

  70. Study completion Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01983215

  71. Primary completion Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01983215

  72. Study completion Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02014818

  73. Primary completion External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02054416

  74. Study completion Stroke and Tocotrienol: Unique Role in Neuroprotection Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02263924

  75. Primary completion Stroke and Tocotrienol: Unique Role in Neuroprotection Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02263924

  76. Primary completion Eplerenone in the Management of Abdominal Aortic Aneurysms Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02345590

  77. Primary completion Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI) Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02512978

  78. Study completion Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02527811

  79. Primary completion Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02538978

  80. Primary completion ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial) Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02609698

  81. Primary completion Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02625948

  82. Study completion A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02641652

  83. Primary completion Bioimpedance Analysis in Chronic Heart Failure Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02662439

  84. Study completion Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02666157

  85. Primary completion Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02666157

  86. Primary completion Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure Management Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02673073

  87. Primary completion Spironolactone in Atrial Fibrillation Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02673463

  88. Study completion In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02678065

  89. Primary completion In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02678065

  90. Study completion Adenosine as an Adjunct to Blood Cardioplegia Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02681913

  91. Study completion Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo. Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02715687

  92. Study completion Temporary Pacemaker in Transcatheter Aortic Valve Implantation Patients Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02768064

  93. Primary completion Integrative Care for Type 2 Diabetes Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02843724

  94. Study completion Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02901704

  95. Primary completion Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction. Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02919059

  96. Study completion Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02933788

  97. Study completion Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03027375

  98. Primary completion Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03027375

  99. Study completion Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03037047

  100. Study completion Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03045562